More recently, Tang et al. (46) hypothesized that omega-3 fatty acids may be of value in enhancing BDNF levels and improving cognitive function in patients with schizophrenia with metabolic syndrome (MetS). The gene discussed is BDNF; the disease is metabolic syndrome.